Lineage Cell Therapeutics, Inc. Quarterly Operating Lease, Liability, Current in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Lineage Cell Therapeutics, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q1 2019 to Q2 2024.
  • Lineage Cell Therapeutics, Inc. Operating Lease, Liability, Current for the quarter ending June 30, 2024 was $1.07M, a 14.6% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.07M +$136K +14.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.05M +$140K +15.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $830K -$86K -9.39% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $881K +$338K +62.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $933K +$340K +57.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $912K +$193K +26.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $916K +$115K +14.4% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $543K -$258K -32.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $593K -$197K -24.9% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $719K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $801K +$55K +7.37% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $801K Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $790K Jun 30, 2021 10-Q 2021-08-12
Q4 2020 $746K Dec 31, 2020 10-K 2022-03-10
Q3 2019 $1.11M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $923K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $923K Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.